Gold nano-probes as targeted CT contrast agents for in-vivo cancer imaging

R. Popovtzer*, M. Shlomi, A. Agrawal, A. Popovtzer, J. Baiter, T. E. Carey, R. Kopelman

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingConference contributionpeer-review

Abstract

This paper describes a new class of immuno-targeted and cancer specific CT contrast agents, which enable CT imaging of cancer at cellular and molecular resolution. The method is based on the development of gold nano-probes that specifically and sensitively target in vivo tumor specific antigens, while inducing distinct contrast in CT imaging (increased x-ray attenuation). The overall goal of this research is to develop a novel cancer imaging tool, which may lead to improvements in therapy due to early detection, accurate staging and micro-tumor identification.

Original languageEnglish
Title of host publicationTechnical Proceedings of the 2008 NSTI Nanotechnology Conference and Trade Show, NSTI-Nanotech, Nanotechnology 2008
Pages5-7
Number of pages3
StatePublished - 2008
Externally publishedYes
Event2008 NSTI Nanotechnology Conference and Trade Show, NSTI Nanotech 2008 Joint Meeting, Nanotechnology 2008 - Quebec City, QC, United States
Duration: 1 Jun 20085 Jun 2008

Publication series

NameTechnical Proceedings of the 2008 NSTI Nanotechnology Conference and Trade Show, NSTI-Nanotech, Nanotechnology 2008
Volume2

Conference

Conference2008 NSTI Nanotechnology Conference and Trade Show, NSTI Nanotech 2008 Joint Meeting, Nanotechnology 2008
Country/TerritoryUnited States
CityQuebec City, QC
Period1/06/085/06/08

Keywords

  • CT contrast agents
  • Gold nanoparticles
  • In-vivo cancer imaging

Fingerprint

Dive into the research topics of 'Gold nano-probes as targeted CT contrast agents for in-vivo cancer imaging'. Together they form a unique fingerprint.

Cite this